Compare Pfizer with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs FULFORD INDIA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER FULFORD INDIA PFIZER/
FULFORD INDIA
 
P/E (TTM) x 36.3 398.8 9.1% View Chart
P/BV x 6.1 6.2 98.6% View Chart
Dividend Yield % 0.6 0.1 658.5%  

Financials

 PFIZER   FULFORD INDIA
EQUITY SHARE DATA
    PFIZER
Mar-19
FULFORD INDIA
Mar-14
PFIZER/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs3,840942 407.6%   
Low Rs2,080450 462.2%   
Sales per share (Unadj.) Rs455.0691.4 65.8%  
Earnings per share (Unadj.) Rs93.811.5 818.2%  
Cash flow per share (Unadj.) Rs109.415.4 712.2%  
Dividends per share (Unadj.) Rs22.502.00 1,125.0%  
Dividend yield (eoy) %0.80.3 264.5%  
Book value per share (Unadj.) Rs658.2380.0 173.2%  
Shares outstanding (eoy) m45.753.90 1,173.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.51.0 646.3%   
Avg P/E ratio x31.660.7 52.0%  
P/CF ratio (eoy) x27.145.3 59.7%  
Price / Book Value ratio x4.51.8 245.5%  
Dividend payout %24.017.4 137.5%   
Avg Mkt Cap Rs m135,4202,714 4,988.9%   
No. of employees `0002.60.4 592.6%   
Total wages/salary Rs m3,238505 641.3%   
Avg. sales/employee Rs Th7,911.46,073.0 130.3%   
Avg. wages/employee Rs Th1,230.91,137.4 108.2%   
Avg. net profit/employee Rs Th1,630.7100.7 1,619.8%   
INCOME DATA
Net Sales Rs m20,8152,696 772.0%  
Other income Rs m1,674125 1,334.8%   
Total revenues Rs m22,4892,822 797.0%   
Gross profit Rs m5,712-46 -12,310.3%  
Depreciation Rs m71415 4,696.7%   
Interest Rs m7310 767.4%   
Profit before tax Rs m6,59954 12,153.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,30910 24,047.9%   
Profit after tax Rs m4,29145 9,598.4%  
Gross profit margin %27.4-1.7 -1,594.7%  
Effective tax rate %35.017.7 197.9%   
Net profit margin %20.61.7 1,243.4%  
BALANCE SHEET DATA
Current assets Rs m27,1671,738 1,562.8%   
Current liabilities Rs m8,917545 1,637.0%   
Net working cap to sales %87.744.3 198.1%  
Current ratio x3.03.2 95.5%  
Inventory Days Days6848 139.9%  
Debtors Days Days304 699.3%  
Net fixed assets Rs m8,86212 74,469.7%   
Share capital Rs m45839 1,173.1%   
"Free" reserves Rs m29,6561,443 2,055.2%   
Net worth Rs m30,1131,482 2,031.9%   
Long term debt Rs m250-   
Total assets Rs m39,4002,077 1,897.2%  
Interest coverage x91.56.7 1,362.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.51.3 40.7%   
Return on assets %11.12.6 424.3%  
Return on equity %14.23.0 472.4%  
Return on capital %22.14.3 514.2%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m42817 2,490.1%   
Fx outflow Rs m786673 116.8%   
Net fx Rs m-358-656 54.6%   
CASH FLOW
From Operations Rs m97890 1,086.8%  
From Investments Rs m351105 335.8%  
From Financial Activity Rs m-1,099-14 7,790.8%  
Net Cashflow Rs m231181 127.9%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 7.5 3.8 197.4%  
FIIs % 4.9 0.1 4,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 21.2 111.8%  
Shareholders   85,207 4,783 1,781.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  NOVARTIS  TTK HEALTHCARE  PROCTER & GAMBLE HEALTH  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Why is Sensex at a Record High When Economy is in Trouble?(Podcast)

In today's episode, I talk about all the major moves of the week, including Modi government's blockbuster disinvestment, developments in the telecom sector.

Related Views on News

PFIZER at All Time High; BSE HEALTHCARE Index Up 0.7% (Market Updates)

Nov 22, 2019 | Updated on Nov 22, 2019

PFIZER share price has hit an all time high at Rs 4,199 (up 1.7%). The BSE HEALTHCARE Index is up by 0.7%. Among the top gainers in the BSE HEALTHCARE Index today are PFIZER (up 1.7%) and ABBOTT INDIA (up 0.6%). The top losers include DR. REDDYS LAB (down 0.1%) and ALKEM LABORATORIES (down 0.3%).

PFIZER at All Time High; BSE HEALTHCARE Index Up 0.3% (Market Updates)

Nov 22, 2019 | Updated on Nov 22, 2019

PFIZER share price has hit an all time high at Rs 4,189 (up 0.6%). The BSE HEALTHCARE Index is up by 0.3%. Among the top gainers in the BSE HEALTHCARE Index today are PFIZER (up 0.6%) and SANOFI INDIA (up 0.4%). The top losers include CADILA HEALTHCARE (down 0.1%) and GSK PHARMA (down 0.2%).

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

How the Modi Government is Helping My Top 7 Stocks(The 5 Minute Wrapup)

Nov 14, 2019

Recent reforms by the Modi government can give a big boost on your stocks, provided you buy the right ones.

I Think Nestle, HUL, and Asian Paints Could Give Low Returns(Profit Hunter)

Nov 15, 2019

If you think high quality stocks will continue their dream run forever, then you must read this now.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Nov 22, 2019 (Close)

TRACK PFIZER

PFIZER - SHASUN PHARMA COMPARISON

COMPARE PFIZER WITH

MARKET STATS